Takara Bio Inc
TSE:4974
Takara Bio Inc
TSE:4974
Price:
1 086 JPY
-1.18%
Market Closed
Updated:
May 18, 2024
Takara Bio Inc
Selling, General & Administrative
|
Takara Bio Inc
Selling, General & Administrative Peer Comparison
Comparables:
2160
4587
2929
J
7774
S
4599
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takara Bio Inc
TSE:4974
|
Selling, General & Administrative
-¥15.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
GNI Group Ltd
TSE:2160
|
Selling, General & Administrative
-¥14.6B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-34%
|
|
|
PeptiDream Inc
TSE:4587
|
Selling, General & Administrative
-¥7.3B
|
CAGR 3-Years
-93%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Selling, General & Administrative
-¥45B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-53%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Selling, General & Administrative
-¥1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
S
|
StemRIM Inc
TSE:4599
|
Selling, General & Administrative
-¥608.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Selling, General & Administrative?
Selling, General & Administrative
-15.6B
JPY
-15.6B
JPY
Based on the financial report for Mar 31, 2024, Takara Bio Inc's Selling, General & Administrative amounts to -15.6B JPY.
What is Takara Bio Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-7%
-7%
Over the last year, the Selling, General & Administrative growth was 0%. The average annual Selling, General & Administrative growth rates for Takara Bio Inc have been -8% over the past three years , -7% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
